Profil
Wilfred G.
Bristow has been a Director of Biovail Corporation since 1994 and serves on the Compensation, Nominating and Corporate Governance Committee.
From January 1993 to February 1994, he was a Director of BCI.
From December 1991 to June 2006, Mr. Bristow was Vice President and Senior Investment Advisor at BMO Nesbitt Burns, Inc. From September 1975 to December 1991, he served as Vice President and a Director of Richardson Greenshields of Canada.
Ehemalige bekannte Positionen von Wilfred G. Bristow
| Unternehmen | Position | Ende |
|---|---|---|
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Direktor/Vorstandsmitglied | 21.04.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
